In this review, we discuss the direct roles of GPER in several cancers, as well as indirect roles based on obesity and metabolism- and immune-related stromal cells, suggesting multiple therapeutic roles for GPER-targeted drugs in the treatment of cancer. The gene discussed is GPER1; the disease is obesity due to melanocortin 4 receptor deficiency.